Trial Profile
A Single-Center, Open Label, Prospective Study Evaluating the Safety and Efficacy of Sofosbuvir and Ribavirin Combination in Patients with Hepatitis C Virus-Associated Cryoglobulinaemia Vasculitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2018
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Cryoglobulinaemia; Hepatitis C; Vasculitis
- Focus Therapeutic Use
- Acronyms VASCUVALDIC
- 12 Aug 2015 New trial record